Zusammenfassung
Hintergrund
Als Dystonien werden hyperkinetische Bewegungsstörungen bezeichnet, die durch anhaltende oder intermittierende Muskelkontraktionen zu Verdrehungen, Verkrampfungen und Tremor führen. Die zervikale Dystonie ist die häufigste Dystonieform, sie betrifft den Kopf‑, Hals- und/oder Schulterbereich. Neben diesen motorischen Symptomen sind Schmerzen und psychiatrische Symptome bei (zervikalen) Dystonien häufig.
Fragestellung
Beschreibung des Vorkommens und der Evaluation von Schmerzen bei zervikaler Dystonie, Zusammenfassung und Diskussion der Behandlungsmöglichkeiten und -wirkungen.
Material und Methoden
Im vorliegenden Übersichtsbeitrag werden die Erkenntnisse aus der wissenschaftlichen Fachliteratur zu Schmerzen bei Dystonien zusammengefasst und diskutiert.
Ergebnisse
Im Vergleich zu anderen Dystonieformen treten Schmerzen bei Patienten mit einer zervikalen Dystonie am häufigsten auf. Ein Großteil der Patienten mit einer zervikalen Dystonie leidet unter Schmerzen. Diese tragen am meisten zur Beeinträchtigung der Patienten bei. Die motorischen Symptome werden meist mit Botulinumtoxininjektionen behandelt. Diese wirken muskelentspannend und zudem auch schmerzlindernd. Die Studienlage zum Vorkommen und zur Therapie von Schmerzen bei anderen Dystonieformen ist bislang sehr limitiert. Der Schmerz kann bei Patienten mit einer zervikalen Dystonie im Vordergrund des Krankheitsbilds stehen. Die Evaluation von Schmerzen bei zervikalen Dystonien kann mittels standardisierter Fragebögen durchgeführt werden.
Schlussfolgerungen
Es ist wichtig, Patienten mit zervikaler Dystonie zu Schmerzen zu befragen und diese in der Therapieplanung und -evaluation zu berücksichtigen. Umgekehrt sollte bei Schmerzen auch an eine Dystonie als mögliche Ursache gedacht werden. Zur Evaluation gibt es teils neu entwickelte Fragebögen, um Schmerzen bei Patienten mit Dystonien standardisiert zu erfassen. Weitere Forschung ist nötig, um die Pathomechanismen der Schmerzen bei Dystonien besser zu verstehen.
Abstract
Background
Dystonia is a hyperkinetic movement disorder that results in twisting, cramps and tremors due to sustained or intermittent muscle contractions. Cervical dystonia is the most common form of dystonia, in which the head, neck and/or shoulder areas are affected. In addition to these motor symptoms, pain and psychiatric symptoms are frequent in (cervical) dystonia.
Objective
Description of the incidence and evaluation of pain in cervical dystonia, summary and discussion of treatment options and effects.
Material and methods
In this review article the results in the scientific literature on pain in dystonia are summarized and discussed.
Results
Compared to other forms of dystonia, pain occurs most frequently in patients with cervical dystonia. A large proportion of patients with cervical dystonia suffer from pain, which contributes most to impairment of the patient. The motor symptoms of dystonia are usually treated with botulinum toxin injections. These have a muscle relaxing effect and also relieve pain. The study situation on the occurrence and treatment of pain in other forms of dystonia is so far very limited. Pain can dominate the clinical picture in patients with cervical dystonia. Evaluation of pain in cervical dystonia can be performed using standardized questionnaires.
Conclusion
It is important to ask patients with cervical dystonia about pain and to consider it in treatment planning and evaluation. Vice versa, if pain is present the possibility of a causative dystonia should also be considered. For pain assessment there are some newly developed questionnaires to assess pain in a standardized way in patients with dystonia. Further research is needed to better understand the pathomechanisms of pain in dystonia.
Literatur
Albanese A, Asmus F, Bhatia KP et al (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18:5–18. https://doi.org/10.1111/j.1468-1331.2010.03042.x
Albanese A, Bhatia K, Bressman SB et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord Off J Mov Disord Soc 28:863–873. https://doi.org/10.1002/mds.25475
Albanese A, Sorbo FD, Comella C et al (2013) Dystonia rating scales: critique and recommendations. Mov Disord 28:874–883. https://doi.org/10.1002/mds.25579
Anis S, Faust-Socher A, Sverdlov D et al (2023) A single-center real-life study on the use of medical cannabis in patients with dystonia. Front Neurol 14:1218300. https://doi.org/10.3389/fneur.2023.1218300
Avenali M, De Icco R, Tinazzi M et al (2018) Pain in focal dystonias—a focused review to address an important component of the disease. Parkinsonism Relat Disord 54:17–24. https://doi.org/10.1016/j.parkreldis.2018.04.030
Barbanti P, Fabbrini G, Pauletti C et al (2005) Headache in cranial and cervical dystonia. Neurology 64:1308–1309. https://doi.org/10.1212/01.WNL.0000156909.13677.FF
Bega D, Park K, Grimone A et al (2018) Acupuncture as aadjuvant tfor the management of cervical dystonia. Med Acupunct 30:198–203. https://doi.org/10.1089/acu.2018.1291
Bradley D, Whelan R, Walsh R et al (2009) Temporal discrimination threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia. Brain J Neurol 132:2327–2335. https://doi.org/10.1093/brain/awp156
Bruno V, Achen B, Morgante F et al (2023) The Pain in Dystonia Scale (PIDS)—development and validation in cervical dystonia. Mov Disord 38:1175–1186. https://doi.org/10.1002/mds.29452
Cano SJ, Warner TT, Linacre JM et al (2004) Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58). Neurology 63:1629–1633. https://doi.org/10.1212/01.wnl.0000142962.11881.26
Casale R, Tugnoli V (2008) Botulinum toxin for pain. Drugs 9:11–27. https://doi.org/10.2165/00126839-200809010-00002
Castelão M, Marques RE, Duarte GS et al (2017) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 12:CD3633. https://doi.org/10.1002/14651858.CD003633.pub3
Chan J, Brin MF, Fahn S (1991) Idiopathic cervical dystonia: clinical characteristics. Mov Disord Off J Mov Disord Soc 6:119–126. https://doi.org/10.1002/mds.870060206
Charles PD, Adler CH, Stacy M et al (2014) Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol 261:1309–1319. https://doi.org/10.1007/s00415-014-7343-6
Comella C, Bhatia K (2015) An international survey of patients with cervical dystonia. J Neurol 262:837–848. https://doi.org/10.1007/s00415-014-7586-2
Comella C, Ferreira JJ, Pain E et al (2021) Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia. J Neurol 268:903–912. https://doi.org/10.1007/s00415-020-10217-7
Consky ES (1990) The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 40:445
De Pauw J, Van der Velden K, Meirte J et al (2014) The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J Neurol 261:1857–1865. https://doi.org/10.1007/s00415-013-7220-8
Deepak R, Mathew H, Koshy M (2010) Effectiveness of acupuncture in cervical dystonia. Acupunct Med J Br Med Acupunct Soc 28:94–96. https://doi.org/10.1136/aim.2009.002048
Defazio G, Abbruzzese G, Livrea P, Berardelli A (2004) Epidemiology of primary dystonia. Lancet Neurol 3:673–678. https://doi.org/10.1016/S1474-4422(04)00907-X
van den Dool J, Tijssen MJ, Koelman MJJHTM et al (2016) Determinants of disability in cervical dystonia. Parkinsonism Relat Disord 32:48–53. https://doi.org/10.1016/j.parkreldis.2016.08.014
Dworkin RH, Turk DC, Farrar JT et al (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113:9–19. https://doi.org/10.1016/j.pain.2004.09.012
Faircloth S, Reid S (2006) A cognitive–behavioural approach to the management of idiopathic cervical dystonia. J Behav Ther Exp Psychiatry 37:239–246. https://doi.org/10.1016/j.jbtep.2005.07.003
Han V, Skorvanek M, Smit M et al (2020) Prevalence of non-motor symptoms and their association with quality of life in cervical dystonia. Acta Neurol Scand 142:613–622. https://doi.org/10.1111/ane.13304
Hefter H, Benecke R, Erbguth F et al (2013) An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ Open 3:e1853. https://doi.org/10.1136/bmjopen-2012-001853
Ip CW, Bäumer T, Ceballos-Baumann A et al (2021) Dystonie, S1-leitlinie
Jankovic J, Leder S, Warner D, Schwartz K (1991) Cervical dystonia: clinical findings and associated movement disorders. Neurology 41:1088–1088. https://doi.org/10.1212/WNL.41.7.1088
Klein C, Fahn S (2013) Translation of Oppenheim’s 1911 paper on dystonia. Mov Disord Off J Mov Disord Soc 28:851–862. https://doi.org/10.1002/mds.25546
Klingelhoefer L, Kaiser M, Sauerbier A et al (2021) Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia. J Neural Transm 1996(128):305–314. https://doi.org/10.1007/s00702-020-02274-z
Kulenkamp J, McClelland CM, Lee MS (2020) Eye pain in the white and quiet eye. Curr Opin Ophthalmol 31:483–488. https://doi.org/10.1097/ICU.0000000000000702
Kutvonen O, Dastidar P, Nurmikko T (1997) Pain in spasmodic torticollis. Pain 69:279–286. https://doi.org/10.1016/S0304-3959(96)03296-4
Medina A, Nilles C, Martino D, Pelletier C, Pringsheim T (2022) The prevalence of idiopathic or inherited isolated dystonia: a systematic review and meta-analysis. Mov Disord Clin Pract 9(7):860–868. https://doi.org/10.1002/mdc3.13524
Lalli S, Albanese A (2010) The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Mov Disord Off J Mov Disord Soc 25:1619–1626. https://doi.org/10.1002/mds.23137
Lim K, See YM, Lee J (2017) A systematic review of the effectiveness of medical cannabis for psychiatric, movement and neurodegenerative disorders. Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol 15:301–312. https://doi.org/10.9758/cpn.2017.15.4.301
Listik C, Listik E, de Paiva Santos Rolim F et al (2023) Development and validation of the dystonia-pain classification system: a multicenter study. Mov Disord 38:1163–1174. https://doi.org/10.1002/mds.29423
Lobbezoo F, Tanguay R, Thon MT, Lavigne GJ (1996) Pain perception in idiopathic cervical dystonia (spasmodic torticollis). Pain 67:483–491. https://doi.org/10.1016/0304-3959(96)03153-3
Lobbezoo F, Thu Thon M, Rémillard G et al (1996) Relationship between sleep, neck muscle activity, and pain in cervical dystonia. Can J Neurol Sci J Can Sci Neurol 23:285–290. https://doi.org/10.1017/s0317167100038233
Macerollo A, Sajin V, Bonello M et al (2020) Deep brain stimulation in dystonia: state of art and future directions. J Neurosci Methods 340:108750. https://doi.org/10.1016/j.jneumeth.2020.108750
Marciniec M, Szczepańska-Szerej A, Papuć E, Rejdak K (2022) Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A. Int J Neurosci 132:1026–1030. https://doi.org/10.1080/00207454.2020.1860039
Mascia MM, Carmagnini D, Defazio G (2020) Cannabinoids and dystonia: an issue yet to be defined. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 41:783–787. https://doi.org/10.1007/s10072-019-04196-5
Muller J, Wissel J, Kemmler G et al (2004) Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 75:749–753. https://doi.org/10.1136/jnnp.2003.013441
Newby R, Muhamed S, Alty J et al (2022) Geste antagoniste effects on motor performance in dystonia—a kinematic study. Mov Disord Clin Pract 9:759–764. https://doi.org/10.1002/mdc3.13505
Novaretti N, Cunha ALN, Bezerra TC et al (2019) The prevalence and correlation of non-motor symptoms in adult patients with idiopathic focal or segmental dystonia. Tremor Hyperkinetic Mov N Y N 9:596. https://doi.org/10.7916/fhnv-v355
Ondo WG, Gollomp S, Galvez-Jimenez N (2005) A pilot study of botulinum toxin A for headache in cervical dystonia. Headache 45:1073–1077. https://doi.org/10.1111/j.1526-4610.2005.05190.x
Pelosin E, Avanzino L, Marchese R et al (2013) kinesiotaping reduces pain and modulates sensory function in patients with focal dystonia: a randomized crossover pilot study. Neurorehabil Neural Repair 27:722–731. https://doi.org/10.1177/1545968313491010
Relja M, Miletić V (2017) When movement disorders hurt: addressing pain in hyperkinetic disorders. Parkinsonism Relat Disord 44:110–113. https://doi.org/10.1016/j.parkreldis.2017.08.011
Richter T, Nestler-Parr S, Babela R et al (2015) Rare disease terminology and definitions—a systematic global review: report of the ISPOR rare disease special interest group. Value Health J Int Soc Pharmacoeconomics Outcomes Res 18:906–914. https://doi.org/10.1016/j.jval.2015.05.008
Rodrigues FB, Duarte GS, Marques RE et al (2020) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 11:CD3633. https://doi.org/10.1002/14651858.CD003633.pub4
Rodrigues FB, Duarte GS, Prescott D et al (2019) Deep brain stimulation for dystonia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012405.pub2
Rosales RL, Cuffe L, Regnault B, Trosch RM (2021) Pain in cervical dystonia: mechanisms, assessment and treatment. Expert Rev Neurother 21:1125–1134. https://doi.org/10.1080/14737175.2021.1984230
Sheehy MP, Marsden CD (1980) Trauma and pain in spasmodic torticollis. Lancet Lond Engl 1:777–778. https://doi.org/10.1016/s0140-6736(80)91281-7
Smit M, Kuiper A, Han V et al (2016) Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: results of a controlled study. Parkinsonism Relat Disord 30:7–12. https://doi.org/10.1016/j.parkreldis.2016.06.004
Tinazzi M, Erro R, Mascia MM et al (2020) Demographic and clinical determinants of neck pain in idiopathic cervical dystonia. J Neural Transm Vienna Austria 1996(127):1435–1439. https://doi.org/10.1007/s00702-020-02245-4
Tinazzi M, Squintani GM, Bhatia KP et al (2019) Pain in cervical dystonia: evidence of abnormal inhibitory control. Parkinsonism Relat Disord 65:252–255. https://doi.org/10.1016/j.parkreldis.2019.06.009
Trosch RM, Espay AJ, Truong D et al (2017) Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: the ANCHOR-CD registry. J Neurol Sci 376:84–90. https://doi.org/10.1016/j.jns.2017.02.042
Vu JP, Lee HY, Chen Q et al (2021) Head tremor and pain in cervical dystonia. J Neurol 268:1945–1950. https://doi.org/10.1007/s00415-020-10378-5
Wadon ME, Bailey GA, Yilmaz Z et al (2021) Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystonia. Brain Behav 11:e2292. https://doi.org/10.1002/brb3.2292
Wadon ME, Winter M, Peall KJ (2020) Internet-based cognitive behavioural therapy programme as an intervention for people diagnosed with adult-onset, focal, isolated, idiopathic cervical dystonia: a feasibility study protocol. Pilot Feasibility Stud 6:100. https://doi.org/10.1186/s40814-020-00641-x
Weissbach A, Pauly MG, Herzog R et al (2022) Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDSGene Review. Mov Disord Off J Mov Disord Soc 37:237–252. https://doi.org/10.1002/mds.28874
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T. Bäumer: Referententätigkeit für Pharmazeutische Unternehmen, die Botulinumtoxin herstellen. F. Hamami gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Hamami, F., Bäumer, T. Schmerzen bei zervikaler Dystonie. Schmerz 38, 41–47 (2024). https://doi.org/10.1007/s00482-024-00790-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00482-024-00790-5